Pharmacopsychiatry 2015; 48(02): 80
DOI: 10.1055/s-0034-1395573
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Re: Over-the-Counter Drugs for the Treatment of Mood and Anxiety Disorders – The Views of German Pharmacists. By J. Hamann, K. Linde, H. D. Schweiger, O. Kusmakow, H. Foerstl, Pharmacopsychiatry 2014; 47: 84–88

K. Rickels
1   Perelman School of Medicine, Psychiatry, Mood and Anxiety Disorders Treatment and Research Program, University of Pennsylvania, Philadelphia, Pennsylvania, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
27 November 2014 (online)

 
  • References

  • 1 Hamann J, Linde K, Schweiger HD et al Over-the-Counter Drugs for the Treatment of Mood and Anxiety Disorders – The Views of German Pharmacists. Pharmacopsychiatry 2014; 47: 84-88
  • 2 Kirsch I, Deacon BJ, Huedo-Medina TB et al Initial Severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLOS Med 2008; 5: 260-268
  • 3 Angell M. The Epidemic of Mental Illness: Why?”. The New York Review of Books 2011; 58: 12
  • 4 Angell M. The Illusions of Psychiatry. The New York Review of Books 2011; 58
  • 5 Rickels K, Downing RW. Drug- and Placebo-Treated Neurotic Outpatients-Pretreatment Levels of Manifest Anxiety. Clinical Improvement, and Side Reactions. Arch Gen Psychiatry 1967; 16: 369-372
  • 6 Rickels K, Lipman R, Raab E. Previous Medication, Duration of Illness And Placebo Response. J Nerv Ment Dis. 1966. 142. 548-554